U
Unisense FertiliTech
And manufactures state-of–the-art instrumentation in the field of in vitro fertilization (ivf)
About Unisense FertiliTech
Fertilitech operates in the fertility treatment industry, specializing in preimplantation genetic testing for aneuploidy (PGT-A). This process involves analyzing embryos for abnormal chromosome numbers, which is a major cause of IVF failure, pregnancy loss, and certain birth defects. The company uses advanced techniques such as next-generation sequencing (NGS) and artificial intelligence (AI) to identify embryos with normal chromosome numbers (euploid), thereby increasing the chances of successful pregnancies. Fertilitech serves fertility clinics and healthcare providers who offer IVF treatments to patients. The business model revolves around providing genetic testing services and related products, generating revenue through service fees and product sales. The company also offers educational resources, webinars, and events to keep clients updated on the latest research and advancements in the field.
Source: Dealroom company dataNews
Open roles
Unisense FertiliTech in the Aarhus ecosystem
The Unisense FertiliTech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Unisense FertiliTech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Unisense FertiliTech on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

